Content Library
2019 Presentations
Moving to Restore Muscle Function in Addition to Slowing Progression
Kenneth Attie, Acceleron Pharma
Duchenne Regulatory Science Consortium (DRSC) Clinical Trial Simulation Tool
Jane Larkindale, Critical Path Institute
Small Molecule Fast Skeletal Muscle Troponin Activators
as Potential Therapeutics for Neuromuscular Diseases
Darren Hwee, Cytokinetics
Focused Evolution of CNS-targeting
AAV Vectors Using Cell Type-
Specific RNA Expression
Mathieu Nonnenmacher, Voyager Therapeutics